NSAID + PPI
Naproxen with esomeprazole
Brand names: Vimovo
Adult dose
Dose: 500/20mg BD
Route: PO
Frequency: BD
Clinical pearls
- Patients requiring NSAID with high upper-GI risk; OA, RA, AS
- Step down PPI when NSAID stopped
Contraindications
- Active GI bleeding/peptic ulcer
- Severe heart failure
- Severe renal impairment
- Aspirin/NSAID hypersensitivity
- 3rd trimester pregnancy
Side effects
- GI upset (lower GI risk than naproxen alone — not zero)
- Cardiovascular events
- Renal impairment
- Long-term PPI effects
Interactions
- Anticoagulants
- ACEi/ARB
- Lithium
- Methotrexate
- Clopidogrel (esomeprazole interaction — minor)
Monitoring
- U&E
- FBC
- BP
Reference: BNF; NICE CG177; https://bnf.nice.org.uk/drugs/naproxen-with-esomeprazole/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022